want to see how m your member of congress is getting from the pharmaceutical companies, or how much searchab. so any questions that you have as far as who's lobbying on this issue and what industry is interested in this bill, it's all out there. it's all public records. the media is free to report on, that individual citizens are free to look up and draw their own conclusions. host: our guest is the senior writer for the weekly standard. previously tony worked for the charlotte observer in north carolina. he was deputy business area there covering banking, real estate, manufacturing and other issues. has a bamplet in political science from duke and communications from the university of north carolina. chapel hill is our next call. independent caller named joe. good morning. caller: good morning. host: what would you like to say? caller: i would like to talk a little bit about interesting how we're presenting this as just valuable information. that we have a spike in lobbying and that's real news. but it's interesting, it's all neutral until we get to the point where we say things like, well,